https://www.selleckchem.com/products/gw9662.html
osuppression, improved safety profile, improved quality of life and no detrimental effects on antitumor efficacy. ClinicalTrials.gov NCT02514447. ClinicalTrials.gov NCT02514447.Anemia is a frequent comorbidity of chronic kidney disease (CKD) and is associated with a considerable burden because of decreased patient health-related quality of life and increased healthcare resource utilization. Based on observational data, anemia is associated with an increased risk of CKD progression, cardiovascular events, and all-cause mortality. The curr
Like
Comment
Share
